Jörg Geiger

Author PubWeight™ 21.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 2007 6.15
2 The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012 2.47
3 Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway. Blood 2005 1.15
4 Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase. Blood 2003 0.96
5 Thrombin stimulation of p38 MAP kinase in human platelets is mediated by ADP and thromboxane A2 and inhibited by cGMP/cGMP-dependent protein kinase. Blood 2006 0.93
6 Platelet regulation by NO/cGMP signaling and NAD(P)H oxidase-generated ROS. Blood Cells Mol Dis 2006 0.91
7 Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways. Blood 2013 0.87
8 Response: platelet transcriptome and proteome--relation rather than correlation. Blood 2013 0.86
9 Determination of ATP and ADP Secretion from Human and Mouse Platelets by an HPLC Assay. Transfus Med Hemother 2013 0.84
10 The good, the bad, the ugly: validating the mass spectrometric analysis of modified peptides. Proteomics 2011 0.83
11 Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation. BMC Syst Biol 2011 0.83
12 Phosphatidylserine surface expression and integrin alpha IIb beta 3 activity on thrombin/convulxin stimulated platelets/particles of different sizes. Br J Haematol 2008 0.81
13 Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling. Proteomics 2013 0.78
14 Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides. Naunyn Schmiedebergs Arch Pharmacol 2011 0.78
15 Inhibition of platelet P2Y12 and alpha2A receptor signaling by cGMP-dependent protein kinase. Biochem Pharmacol 2002 0.77
16 A Boolean view separates platelet activatory and inhibitory signalling as verified by phosphorylation monitoring including threshold behaviour and integrin modulation. Mol Biosyst 2013 0.76
17 Dynamical modelling of prostaglandin signalling in platelets reveals individual receptor contributions and feedback properties. Mol Biosyst 2013 0.76
18 A comparative analysis of the bistability switch for platelet aggregation by logic ODE based dynamical modeling. Mol Biosyst 2014 0.75